Podcaster Joe Rogan recently ignited a firestorm of criticism when he told his millions of followers that he contracted coronavirus and felt “pretty good” after just a few days following his use of alternative medical treatments like ivermectin.
Rogan told his audience that he had only one “bad day” but felt almost one hundred percent three days later.
“So, I got back from the road Saturday night feeling very weary, I had a headache, and I felt just rundown. And just to be cautious, I separated from my family, slept in a different part of the house, and throughout the night I got fevers and sweats and I knew what was going on. So, I got up in the morning, got tested, and it turns out I got Covid.
So, we immediately threw the kitchen sink at it. All kinds of meds: monoclonal antibodies, Ivermectin, Z-Pack, Prednisone, everything. I also got a NAD drip and a vitamin drip. I did that three days in a row.”
Media figures from national news outlets like CNN were especially critical of the fact that Rogan took ivermectin – a drug that hundreds of doctors are prescribing to treat COVID patients – falsely accusing him of taking a horse dewormer medicine.
During a podcast following Rogan shaking the virus, Rogan talked about potentially suing CNN for spreading lies about him:
“Do I have to sue CNN? They’re making s*** up — they keep saying I’m taking horse dewormer. I literally got it from a doctor. It’s an American company — they won the Nobel Prize in 2015 for use in human beings, and CNN is saying I’m taking horse dewormer. They must know that’s a lie.”
According to hundreds of studies on the efficacy of alternative treatments for COVID, Ivermectin is scientifically proven to show a high success rate in early improvement.
Because of the apparent misinformation about some treatments in the national media, many Americans are accusing news outlets of being ‘in bed’ with the pharmaceutical industry. According to a recent report, Pfizer is planning on recommending their new twice-per-day COVID pill the company is developing alongside their proprietary vaccines.
“Success against COVID19 will likely require both vaccines & treatments,” Pfizer CEO Albert Bourla said on Twitter recently. “We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate-specifically designed to combat SARS-CoV-2-in non-hospitalized, low-risk adults.”
Two COVID-19 antiviral pills are now in Phase 3 trials and are bringing claims by the national and international media that a proven oral treatment will soon be available to quell the SARS-CoV-2 infection.
Pfizer’s PF-07321332, in combination with the HIV antiviral ritonavir, has begun Phase 2/3 testing as a treatment for people who are infected with SARS-CoV-2 but who are less likely to be hospitalized with COVID-19.
Merck & Co. with partner Ridgeback Biotherapeutics is well into a Phase 3 trial of molnupiravir as a treatment for people who are in early infection. The firms announced this week that they are enrolling uninfected people who live with someone who is COVID-19 positive in a new Phase 3 trial to test the small molecule’s ability to prevent SARS-CoV-2 infection.
Aside from the hundreds of studies proving the efficacy of drugs like Ivermectin in fighting COVID-19, other major studies prove the safety of the drug. A massive expert medical review shows that unless you have a high parasite load, Ivermectin is effectively safer than Tylenol. The study found no accidental Ivermectin overdoses including in infants and young children that had a lethal outcome, out of billions of doses given.
One example in the review described someone who took a suicidal dose of Ivermectin, and after treatment still survived.
“A suicidal intake of ivermectin was reported in a 19-year-old woman with severe
Loa-Lao filariasis. She developed nausea and vomiting, and moderate neurological
manifestations including ataxia, reactive mydriasis, and hyperreflexia after possibly
ingesting 100 times the recommended therapeutic dose (≈400 3-mg ivermectin
tablets). She received conventional supportive treatment and could be discharged from
the hospital on day 4 post-ingestion [Djeunga et al., 2019].”
Additionally, the CDC currently recommends that the government require certain refugees to take Ivermectin in order to enter the US.
“Prior to departure for the United States, all refugees originating from the Middle East, Asia, North Africa, Latin American, & Caribbean should receive presumptive therapy with ivermectin for Strongyloides infection and with albendazole for infections caused by soil-transmitted helminths. Dosing for ivermectin may be based on weight and available tablet size.”